Samuel Kerr

Samuel Kerr

Auto-generated profile, based on publicly available information

Samuel Kerr

Department of Pathology, Yale School of Medicine, New Haven, Connecticut

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2018 in mBio
Verified
Journal Article
Open access
PDF file
LVLeah R. Vincent
Leah R. Vincent
SKSamuel R. Kerr
Samuel R. Kerr
YTYang Tan
Yang Tan
JTJoshua Tomberg
Joshua Tomberg
ERErica L. Raterman
Erica L. Raterman
AJAnn Jerse
Ann Jerse
Resistance to ceftriaxone in Neisseria gonorrhoeae is mainly conferred by mosaic penA alleles that encode penicillin-binding protein 2 (PBP2) variants with markedly lower rates of acylation by ceftriaxone. To assess the impact of these mosaic penA alleles on gonococcal fitness, we introduced the mosaic penA alleles from two ceftriaxone-resistant (Cro r ) clinical isolates (H041 and F89) into a Cro s strain (FA19) by allelic exchange and showed that the resultant Cro r mutants were significantly outcompeted by the Cro s parent strain in vitro and in a murine infection model. Four Cro r compensatory mutants of FA19 penA41 were isolated independently from mice that outcompeted the parent strain both in vitro and in vivo . One of these compensatory mutants (LV41C) displayed a unique growth profile, with rapid log growth followed by a sharp plateau/gradual decline at stationary phase. Genome sequencing of LV41C revealed a mutation (G348D) in the acnB gene encoding the bifunctional aconitate hydratase 2/2 methylisocitrate dehydratase. Introduction of the acnB G348D allele into FA19 penA41 conferred both a growth profile that phenocopied that of LV41C and a fitness advantage, although not as strongly as that exhibited by the original compensatory mutant, suggesting the existence of additional compensatory mutations. The mutant aconitase appears to be a functional knockout with lower activity and expression than wild-type aconitase. Transcriptome sequencing (RNA-seq) analysis of FA19 penA41 acnB G348D revealed a large set of upregulated genes involved in carbon and energy metabolism. We conclude that compensatory mutations can be selected in Cro r gonococcal strains that increase metabolism to ameliorate their fitness deficit. IMPORTANCE The emergence of ceftriaxone-resistant (Cro r ) Neisseria gonorrhoeae has led to the looming threat of untreatable gonorrhea. Whether Cro resistance is likely to spread can be predicted from studies that compare the relative fitnesses of susceptible and resistant strains that differ only in the penA gene that confers Cro resistance. We showed that mosaic penA alleles found in Cro r clinical isolates are outcompeted by the Cro s parent strain in vitro and in vivo but that compensatory mutations that allow ceftriaxone resistance to be maintained by increasing bacterial fitness are selected during mouse infection. One compensatory mutant that was studied in more detail had a mutation in acnB , which encodes the aconitase that functions in the tricarboxylic acid (TCA) cycle. This study illustrates that compensatory mutations can be selected during infection, which we hypothesize may allow the spread of Cro resistance in nature. This study also provides novel insights into gonococcal metabolism and physiology.

13 February 2026 in Cancer Immunology Research
Verified
Journal Article
Closed access
GCGianfilippo Coppola
Gianfilippo Coppola
SKSamuel Kerr
Samuel Kerr
PCPei-Chun Cha
Pei-Chun Cha
ABAlexey Bersenev
Alexey Bersenev
KOKelly Olino
Kelly Olino
SKSamuel G. Katz
Samuel G. Katz
Tumor-infiltrating lymphocytes (TIL) can be isolated from patient tumors, greatly expanded ex vivo, and returned to the patient for therapeutic effect. Recent clinical trials have highlighted the efficacy of TILs for a subset of patients and supported FDA approval for melanoma. How TILs evolve during the manufacturing process is still unknown and likely critical to improving the therapy for more patients. To characterize cell modification during TIL expansion, we performed single-cell RNA and T-cell receptor sequencing of TILs isolated from patient tumors and their paired ex vivo expanded cell products. We found large transcriptional differences between pre- and post-expansion TILs. Post-expansion TILs were predominantly exhausted and lacked naïve or memory cell phenotypes, including a decreased percentage of CD39/CD69 double-negative (DN) “stem-like” T cells. Coactivating receptors CD137 and CD27 decreased, whereas CD30 increased. Among coinhibitory receptors, PDCD1 (PD-1) decreased, whereas HAVCR2 (TIM3) and LAG3 showed the largest increases with expansion. Other gene families that showed large increases with ex vivo growth included cytotoxicity- and APC-associated genes. Individual clonotypes were distributed among multiple cell differentiation states, which exhibited high degrees of plasticity during expansion. Although ex vivo expanded TILs are predominantly terminally differentiated, exhausted, and transcriptionally highly distinct from the initial TILs, there is also a large progenitor exhausted CD8 T-cell population, and DN numbers increase. Future work to amplify subpopulations of TILs with memory cell phenotypes, such as the DN cells, will likely further improve this therapy.

18 June 2026
Verified
Other
Open access
GCGianfilippo Coppola
Gianfilippo Coppola
SKSamuel Kerr
Samuel Kerr
PCPei-Chun Cha
Pei-Chun Cha
ABAlexey Bersenev
Alexey Bersenev
KOKelly Olino
Kelly Olino
SKSamuel G. Katz
Samuel G. Katz
Comparative analysis of co-inhibitory receptor and MHCII antigen presentation molecule expression in CD4+ TIL during expansion by cell state

18 June 2026
Verified
Other
Open access
GCGianfilippo Coppola
Gianfilippo Coppola
SKSamuel Kerr
Samuel Kerr
PCPei-Chun Cha
Pei-Chun Cha
ABAlexey Bersenev
Alexey Bersenev
KOKelly Olino
Kelly Olino
SKSamuel G. Katz
Samuel G. Katz
Tumor-infiltrating lymphocytes (TIL) can be isolated from patient tumors, greatly expanded ex vivo, and returned to the patient for therapeutic effect. Recent clinical trials have highlighted the efficacy of TILs for a subset of patients and supported FDA approval for melanoma. How TILs evolve during the manufacturing process is still unknown and likely critical to improving the therapy for more patients. To characterize cell modification during TIL expansion, we performed single-cell RNA and T-cell receptor sequencing of TILs isolated from patient tumors and their paired ex vivo expanded cell products. We found large transcriptional differences between pre- and post-expansion TILs. Post-expansion TILs were predominantly exhausted and lacked naïve or memory cell phenotypes, including a decreased percentage of CD39/CD69 double-negative (DN) “stem-like” T cells. Coactivating receptors CD137 and CD27 decreased, whereas CD30 increased. Among coinhibitory receptors, PDCD1 (PD-1) decreased, whereas HAVCR2 (TIM3) and LAG3 showed the largest increases with expansion. Other gene families that showed large increases with ex vivo growth included cytotoxicity- and APC-associated genes. Individual clonotypes were distributed among multiple cell differentiation states, which exhibited high degrees of plasticity during expansion. Although ex vivo expanded TILs are predominantly terminally differentiated, exhausted, and transcriptionally highly distinct from the initial TILs, there is also a large progenitor exhausted CD8 T-cell population, and DN numbers increase. Future work to amplify subpopulations of TILs with memory cell phenotypes, such as the DN cells, will likely further improve this therapy.


18 June 2026
Verified
Other
Open access
GCGianfilippo Coppola
Gianfilippo Coppola
SKSamuel Kerr
Samuel Kerr
PCPei-Chun Cha
Pei-Chun Cha
ABAlexey Bersenev
Alexey Bersenev
KOKelly Olino
Kelly Olino
SKSamuel G. Katz
Samuel G. Katz
Comparative analysis of co-inhibitory receptor and MHC-II antigen presentation molecule expression in CD8+ TIL during expansion by cell state